Literature DB >> 28116566

An Integrated Soft Computing Approach to Hughes Syndrome Risk Assessment.

João Vilhena1, M Rosário Martins2, Henrique Vicente1,3, José M Grañeda4, Filomena Caldeira4, Rodrigo Gusmão4, João Neves5, José Neves6.   

Abstract

The AntiPhospholipid Syndrome (APS) is an acquired autoimmune disorder induced by high levels of antiphospholipid antibodies that cause arterial and veins thrombosis, as well as pregnancy-related complications and morbidity, as clinical manifestations. This autoimmune hypercoagulable state, usually known as Hughes syndrome, has severe consequences for the patients, being one of the main causes of thrombotic disorders and death. Therefore, it is required to be preventive; being aware of how probable is to have that kind of syndrome. Despite the updated of antiphospholipid syndrome classification, the diagnosis remains difficult to establish. Additional research on clinically relevant antibodies and standardization of their quantification are required in order to improve the antiphospholipid syndrome risk assessment. Thus, this work will focus on the development of a diagnosis decision support system in terms of a formal agenda built on a Logic Programming approach to knowledge representation and reasoning, complemented with a computational framework based on Artificial Neural Networks. The proposed model allows for improving the diagnosis, classifying properly the patients that really presented this pathology (sensitivity higher than 85%), as well as classifying the absence of APS (specificity close to 95%).

Entities:  

Keywords:  Antiphospholipid syndrome; Artificial neuronal networks; Knowledge representation and reasoning; Logic programming; Systemic autoimmune diseases

Mesh:

Year:  2017        PMID: 28116566     DOI: 10.1007/s10916-017-0688-5

Source DB:  PubMed          Journal:  J Med Syst        ISSN: 0148-5598            Impact factor:   4.460


  15 in total

1.  Tissue factor in antiphospholipid syndrome: shifting the focus from coagulation to endothelium.

Authors:  O Amengual; T Atsumi; M A Khamashta
Journal:  Rheumatology (Oxford)       Date:  2003-03-31       Impact factor: 7.580

Review 2.  Guidelines on the investigation and management of antiphospholipid syndrome.

Authors:  David Keeling; Ian Mackie; Gary W Moore; Ian A Greer; Michael Greaves
Journal:  Br J Haematol       Date:  2012-02-08       Impact factor: 6.998

Review 3.  Challenges in the diagnosis of the antiphospholipid syndrome.

Authors:  Katrien Devreese; Marc F Hoylaerts
Journal:  Clin Chem       Date:  2010-04-01       Impact factor: 8.327

4.  Efficacy of the antiphospholipid score for the diagnosis of antiphospholipid syndrome and its predictive value for thrombotic events.

Authors:  Kotaro Otomo; Tatsuya Atsumi; Olga Amengual; Yuichiro Fujieda; Masaru Kato; Kenji Oku; Tetsuya Horita; Shinsuke Yasuda; Takao Koike
Journal:  Arthritis Rheum       Date:  2012-02

5.  Data mining in soft computing framework: a survey.

Authors:  S Mitra; S K Pal; P Mitra
Journal:  IEEE Trans Neural Netw       Date:  2002

6.  Trends and disparities in coronary heart disease, stroke, and other cardiovascular diseases in the United States: findings of the national conference on cardiovascular disease prevention.

Authors:  R Cooper; J Cutler; P Desvigne-Nickens; S P Fortmann; L Friedman; R Havlik; G Hogelin; J Marler; P McGovern; G Morosco; L Mosca; T Pearson; J Stamler; D Stryer; T Thom
Journal:  Circulation       Date:  2000-12-19       Impact factor: 29.690

7.  Validation of the Sapporo criteria for antiphospholipid syndrome.

Authors:  M D Lockshin; L R Sammaritano; S Schwartzman
Journal:  Arthritis Rheum       Date:  2000-02

Review 8.  Clinical and epidemiological aspects in the antiphospholipid syndrome.

Authors:  Ricard Cervera; Ronald A Asherson
Journal:  Immunobiology       Date:  2003       Impact factor: 3.144

9.  Abstract computation in schizophrenia detection through artificial neural network based systems.

Authors:  L Cardoso; F Marins; R Magalhães; N Marins; T Oliveira; H Vicente; A Abelha; J Machado; J Neves
Journal:  ScientificWorldJournal       Date:  2015-03-05

Review 10.  Antiphospholipid syndrome in 2014: more clinical manifestations, novel pathogenic players and emerging biomarkers.

Authors:  Pier Luigi Meroni; Cecilia Beatrice Chighizola; Francesca Rovelli; Maria Gerosa
Journal:  Arthritis Res Ther       Date:  2014       Impact factor: 5.156

View more
  1 in total

Review 1.  Artificial Intelligence in Clinical Decision Support: a Focused Literature Survey.

Authors:  Stefania Montani; Manuel Striani
Journal:  Yearb Med Inform       Date:  2019-08-16
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.